New workflows for personalised therapy in cancers
For clinical oncology providers, knowing the potential and the limitations of DNA sequencing can be critical for delivering genomic-supported care for patients. Thanks to technological advances a high-throughput of Next Generation Sequencing (NGS) can be applied in standard clinical practice. Amassed protocols for the analysis and interpretation of NGS data and knowledge bases, will allow clinicians to provide more targeted care for their patients. The EU funded Instand-NGS4P project will develop innovative NGS workflows from sample-pre-analytics focusing on conditions of patients for routine diagnostic of common-and-rare juvenile-and-adult cancers. A fully integrated and standardised NGS will be created with cooperation with leading medical centres with experience in NGS platforms in research, European patient advocacy groups and standardisation organisations.
Aufforderung zur Vorschlagseinreichung
Andere Projekte für diesen Aufruf anzeigen
FinanzierungsplanPCP - Pre-Commercial Procurement